ApoA-IMALLORCA impairs LCAT activation and induces dominant familial hypoalphalipoproteinemia

ApoA-IMALLORCA impairs LCAT activation and induces dominant familial hypoalphalipoproteinemia

Apolipoprotein (apo)A-I is the major protein component of HDL and the cofactor for LCAT. We describe a large Spanish kindred, living in the Mediterranean Island of Mallorca, that presents a dominant form of hypoalphalipoproteinemia. The lipid profile of this family was studied because the proband, a...

Full description

Bibliographic Details
Main Authors:	Jesús M. Martín-Campos, Josep Julve, Joan Carles Escolà, Jordi Ordóñez-Llanos, Joaquin Gómez, Jaume Binimelis, Francesc González-Sastre, Francisco Blanco-Vaca
Format:	Article
Language:	English
Published:	Elsevier 2002-01-01
Series:	Journal of Lipid Research
Subjects:	apolipoprotein atherosclerosis coronary heart disease high density lipoprotein molecular diagnosis
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520301942

Similar Items

ApoA-IV modulates the secretory trafficking of apoB and the size of triglyceride-rich lipoproteins
by: Richard B. Weinberg, et al.
Published: (2012-04-01)

Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I*
by: Brian J. Van Lenten, et al.
Published: (2008-11-01)

Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis
by: Eftaxia-Konstantina Valanti, et al.
Published: (2018-10-01)

Endothelial lipase is less effective at influencing HDL metabolism in vivo in mice expressing apoA-II
by: Uli C. Broedl, et al.
Published: (2006-10-01)

Evidence for a complex relationship between apoA-V and apoC-III in patients with severe hypertriglyceridemia
by: Frank G. Schaap, et al.
Published: (2006-10-01)

Quality control in the apoA-I secretory pathway
by: Shaila Bhat, et al.
Published: (2004-07-01)

Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia
by: Joan Carles Escolà-Gil, et al.
Published: (2000-08-01)

Secretion of apoB- and apoA-I-containing lipoproteins by chick kidney
by: Patrizia Tarugi, et al.
Published: (1998-04-01)

Dietary fat modulation of apoA-II metabolism and prevention of senile amyloidosis in the senescence- accelerated mouse
by: Makiko Umezawa, et al.
Published: (2003-04-01)

ApoE2-associated hypertriglyceridemia is ameliorated by increased levels of apoA-V but unaffected by apoC-III deficiency*
by: Gery Gerritsen, et al.
Published: (2008-05-01)

Identification of ApoA4 as a sphingosine 1-phosphate chaperone in ApoM- and albumin-deficient mice
by: Hideru Obinata, et al.
Published: (2019-11-01)

Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally[S]
by: Mohamad Navab, et al.
Published: (2011-06-01)

Subcutaneous Administration of Apolipoprotein J-Derived Mimetic Peptide <span style="font-variant: small-caps">d</span>-[113–122]apoJ Improves LDL and HDL Function and Prevents Atherosclerosis in LDLR-KO Mice
by: Andrea Rivas-Urbina, et al.
Published: (2020-05-01)

Circulating HDL levels control hypothalamic astrogliosis via apoA-I
by: Anna Götz, et al.
Published: (2018-09-01)

Structure dynamics of ApoA-I amyloidogenic variants in small HDL increase their ability to mediate cholesterol efflux
by: Oktawia Nilsson, et al.
Published: (2021-01-01)

ApoA-I-Mediated Lipoprotein Remodeling Monitored with a Fluorescent Phospholipid
by: Edward B. Neufeld, et al.
Published: (2019-07-01)

ApoA-I cleaved by transthyretin has reduced ability to promote cholesterol efflux and increased amyloidogenicity
by: Márcia Almeida Liz, et al.
Published: (2007-11-01)

Correction of hypoalphalipoproteinemia in LDL receptor-deficient rabbits by lecithin:cholesterol acyltransferase
by: Margaret E. Brousseau, et al.
Published: (1998-08-01)

Model class A and class L peptides increase the production of apoA-I-containing lipoproteins in HepG2 cells
by: Nassrin Dashti, et al.
Published: (2004-10-01)

Human apoA-I[Lys107del] mutation affects lipid surface behavior of apoA-I and its ability to form large nascent HDL
by: Irina N. Gorshkova, et al.
Published: (2023-02-01)

SR-BI-mediated selective lipid uptake segregates apoA-I and apoA-II catabolism
by: Maria C. de Beer, et al.
Published: (2005-10-01)

On the hepatic mechanism of HDL assembly by the ABCA1/apoA-I pathway
by: Maki Tsujita, et al.
Published: (2005-01-01)

Regulation of macrophage apoE secretion and sterol efflux by the LDL receptor
by: Danijela Lucic, et al.
Published: (2007-02-01)

LCAT deficiency does not impair amyloid metabolism in APP/PS1 mice[S]
by: Sophie Stukas, et al.
Published: (2014-08-01)

Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins
by: Shucun Qin, et al.
Published: (2000-02-01)

A novel approach to oral apoA-I mimetic therapy[S]
by: Arnab Chattopadhyay, et al.
Published: (2013-04-01)

Role of LCAT in HDL remodeling: investigation of LCAT deficiency states
by: Bela F. Asztalos, et al.
Published: (2007-03-01)

Phospholipids mediated conversion of HDLs generates specific apoA-II pre-β mobility particles
by: Małgorzata Wróblewska, et al.
Published: (2009-04-01)

Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein
by: Francisco Blanco-Vaca, et al.
Published: (2001-11-01)

The effect of weight loss on HDL subfractions and LCAT activity in two genotypes of APOA-II -265T>C polymorphism
by: Masoumeh Moradi, et al.
Published: (2017-05-01)

ApoA5 knockdown improves whole-body insulin sensitivity in high-fat-fed mice by reducing ectopic lipid content
by: João Paulo G. Camporez, et al.
Published: (2015-03-01)

Significance of the hydrophobic residues 225–230 of apoA-I for the biogenesis of HDL1[S]
by: Panagiotis Fotakis, et al.
Published: (2013-12-01)

HDLs in apoA-I transgenic Abca1 knockout mice are remodeled normally in plasma but are hypercatabolized by the kidney
by: Ji-Young Lee, et al.
Published: (2005-10-01)

The ratio of HDL-C to apoA-I interacts with free triiodothyronine to modulate coronary artery disease risk
by: Li Li, et al.
Published: (2021-10-01)

ApoE genotype affects allele-specific apo[a] levels for large apo[a] sizes in African Americans: the Harlem-Basset Studys⃞
by: Erdembileg Anuurad, et al.
Published: (2007-03-01)

Abnormal in vivo metabolism of apoB-containing lipoproteins in human apoE deficiency
by: Katsunori Ikewaki, et al.
Published: (2004-07-01)

Overexpression of SR-BI by adenoviral vector promotes clearance of apoA-I, but not apoB, in human apoB transgenic mice
by: Nancy R. Webb, et al.
Published: (2002-09-01)

Characterization of apoM in normal and genetically modified mice
by: Kirsten Faber, et al.
Published: (2004-07-01)

Discoidal HDL and apoA-I-derived peptides improve glucose uptake in skeletal muscle
by: Jonathan Dalla-Riva, et al.
Published: (2013-05-01)

ApoE knockout and knockin mice: the history of their contribution to the understanding of atherogenesis
by: Godfrey S. Getz, et al.
Published: (2016-05-01)